Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

NUWE

Newellis (NUWE)

Newellis Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NUWE
일자시간출처헤드라인심볼기업
2024/05/1806:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NUWENewellis Inc
2024/05/1806:20Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NUWENewellis Inc
2024/05/1422:00GlobeNewswire Inc.Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaNASDAQ:NUWENewellis Inc
2024/05/0922:00GlobeNewswire Inc.Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
2024/05/0906:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
2024/05/0906:26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:NUWENewellis Inc
2024/05/0721:00GlobeNewswire Inc.Nuwellis, Inc. Announces First Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
2024/05/0222:00GlobeNewswire Inc.Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyNASDAQ:NUWENewellis Inc
2024/05/0107:09GlobeNewswire Inc.Nuwellis Announces Closing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
2024/05/0105:41GlobeNewswire Inc.Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:NUWENewellis Inc
2024/04/2622:17GlobeNewswire Inc.Nuwellis Announces Pricing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
2024/04/0922:00GlobeNewswire Inc.Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthNASDAQ:NUWENewellis Inc
2024/03/1206:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUWENewellis Inc
2024/03/0723:08GlobeNewswire Inc.Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
2024/03/0702:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
2024/03/0522:00GlobeNewswire Inc.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUWENewellis Inc
2024/03/0520:05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:NUWENewellis Inc
2024/02/2723:00GlobeNewswire Inc.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:NUWENewellis Inc
2024/02/2221:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:NUWENewellis Inc
2024/02/2107:06GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
2024/02/2022:42GlobeNewswire Inc.Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
2024/02/0907:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
2024/02/0623:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
2024/02/0623:00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
2024/01/1007:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
2024/01/0823:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
2024/01/0506:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
2024/01/0505:05GlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
2023/12/1406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
2023/11/2822:00GlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
 검색 관련기사 보기:NASDAQ:NUWE